Use treatment  (Esomeprazole ) MOA?inhibits gastric acid secretion and is indicated in the treatment of gastroesophageal reflux disease (GERD), the healing of erosive esophagitis, and H. pylori eradication to reduce the risk of duodenal ulcer recurrence.This effect is dose-related and leads to inhibition of both basal and stimulated acid secretion irrespective of the stimulus